April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Regulation of Ocular Functions by Dopamine and Melatonin
Author Affiliations & Notes
  • Gianluca Tosini
    Pharmacology, Morehouse School of Medicine, Atlanta, GA
  • Kenkichi Baba
    Pharmacology, Morehouse School of Medicine, Atlanta, GA
  • Footnotes
    Commercial Relationships Gianluca Tosini, None; Kenkichi Baba, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 362. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gianluca Tosini, Kenkichi Baba; Regulation of Ocular Functions by Dopamine and Melatonin. Invest. Ophthalmol. Vis. Sci. 2014;55(13):362.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Previous studies have shown that the retina, the retinal pigment epithelium (RPE) and the cornea contain a circadian clock that controls the circadian rhythms in PER2::LUC bioluminescence. Additional studies have indicated that only in the retina the PER2::LUC rhythm can be phase-shifted by light, thus suggesting that other signals are used by the retina to entrain the circadian rhythms in other ocular structures. Melatonin (MLT) and dopamine (DA) are known to be the key molecules to regulated retinal circadian rhythms. In this study we investigated the role of DA and MLT to and their associated receptors in the regulation of RPE and cornea circadian rhythm.

Methods: Eyes were obtained from PER2::LUC mice, the eye-cups were dissected, and the retina, RPE-choroid and cornea were cultured at 37 oC with 199 medium containing 0.1mM D-Luciferin K salt. The bioluminescence emitted by these tissues was measured using a LumiCycle. After 3-4 days of culture, DA (100uM), MLT (100nM) and DA or MLT receptor agonists were added to the culture at different circadian times, and the recording was continued another 5 days. Activity of focal adhesion kinase (pFAK/FAK) in control and D2R knock-out mice was measured by western blotting whereas central corneal thickness (CCT) in mice lacking melatonin receptors was measured using a ultrasound pachometer, Corneo-Gage Plus 1AS.

Results: Administration of DA, but not MLT, phase-shifted PER2::LUC bioluminescence rhythm in the RPE-choroid. Sumanirole (D2R agonist) induced a significant phase-shift during the late night -early subjective day, whereas PD168077 (D4R agonist) did not produce a significant phase-shift of the PER2::LUC bioluminescence rhythm. Conversely, administration of MLT, but not DA, phase-shifted PER2::LUC bioluminescence rhythm in the cornea. Mice lacking D2R signaling showed a change in the timing of the daily rhythm in FAK activation whereas removal MLT signaling affected the daily rhythm in CCT.

Conclusions: Our data indicate that DA via D2 receptors can phase-shift the circadian rhythm in PER2::LUC bioluminescence rhythm in the mouse RPE, whereas MLT can phase-shift the circadian rhythm in PER2::LUC bioluminescence in the cornea. Thus indicating that the retina uses DA and MLT to entrain other tissues within the eye. Our data also indicate that activation of these signaling pathways is the correct timing of circadian functions in these tissues.

Keywords: 458 circadian rhythms • 590 melatonin • 502 dopamine  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.